BUILT IN GHANA. DESIGNED FOR AFRICA.
INSIGHT & EVIDENCE
Africa’s healthcare
decisions deserve
African evidence.
High-stakes decisions about markets, patients and access.
Locally relevant evidence to move forward with confidence.
MARKET INTELLIGENCE / REAL-WORLD EVIDENCEGHANA AFRICA
THE EVIDENCE GAP
The cost of deciding
without local evidence
is too high.
A launch plan. An access case. A healthcare investment. Every consequential decision rests on assumptions about the people and markets it is meant to serve.
Africa does not lack information. The challenge is fragmentation, uneven quality and turning what exists into evidence you can actually use.
Understand the opportunityTHE CONTEXT. NOT OUR CLAIMS.Why evidence, why now
Local health-product manufacturing ambition by 2040
Africa CDC / African Union · 2026Africa · declared future targetOf Ghana’s medicines sourced from outside the country
WHO Ghana · 2025Ghana · pharmaceutical supplyWHAT WE HELP YOU DECIDE
Not more information.
A clearer answer.
We begin with your question—not a generic dataset. Five decision areas. One question-led evidence partner.
Market readiness
Understand patient need, market context, access constraints and adoption considerations before committing to a launch or investment.
Patient & treatment intelligence
Build a locally relevant view of diagnosis, referral, treatment and follow-up—and the gaps that change the decision.
HCP & stakeholder intelligence
Understand clinical perspectives, institutional priorities and implementation barriers in the market you need to serve.
Real-world evidence
Explore fit-for-purpose questions about treatment patterns, outcomes and healthcare utilisation, subject to feasibility and governance.
Evidence strategy
Clarify what is known, where uncertainty remains and which evidence questions deserve your next investment.
Explore our solutions Subject to feasibility, governance, permissions and data quality.
THE I&E PRINCIPLE
From uncertainty to
a decision you can defend.
Tell us what you need to decide. We assess what can responsibly be established and shape the right path to an actionable answer.
01Question
02Evidence
03Answer
04Decision
QUESTION-LED. FIT-FOR-PURPOSE. RESPONSIBLY GOVERNED.Our principles
THE FOUNDER
RMCLINICAL CONTEXT.
COMMERCIAL FOCUS.
COMMERCIAL FOCUS.
Dr. Richeal Shola Makinde
Founder & CEO · Medical Doctor
CREDIBILITY, NOT CLAIMS
Clinical context.
Commercial focus.
African ambition.
A medical doctor building a healthcare-evidence company at the intersection of clinical understanding, pharmaceutical strategy and African market needs.
Professional project experience with Roche Products Ghana includes breast-cancer pipeline market fit, a market-readiness assessment framework and curation of potential real-world evidence sources.
This was personal professional project experience—not an I&E client engagement, Roche endorsement or claim of access to Roche data.Meet the people behind I&EOUR STARTING POINT IS NOT OUR LIMIT
Ghana first.
Africa next.
We are building toward a trusted African evidence company—making locally relevant healthcare evidence easier to responsibly develop and use in consequential decisions.
Help build what comes next GHANA → AFRICATHE NEXT DECISION STARTS WITH A QUESTION
What do you need
to know before you act?
Bring us the healthcare decision you are facing.
Let’s determine what evidence can answer it.